Brown, Lisle/Cummings’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$463K Buy
5,100
+394
+8% +$36K 0.1% 167
2026
Q1
$483K Hold
4,706
0.12% 152
2025
Q4
$590K Buy
4,706
+600
+15% +$76.4K 0.15% 137
2025
Q3
$550K Sell
4,106
-95
-2% -$12.5K 0.14% 145
2025
Q2
$571K Buy
4,201
+57
+1% +$7.52K 0.15% 136
2025
Q1
$550K Buy
4,144
+30
+0.7% +$3.82K 0.16% 133
2024
Q4
$465K Buy
4,114
+35
+0.9% +$4.04K 0.14% 148
2024
Q3
$465K Buy
4,079
+525
+15% +$57.6K 0.14% 142
2024
Q2
$369K Buy
3,554
+1,124
+46% +$119K 0.12% 158
2024
Q1
$276K Hold
2,430
0.09% 175
2023
Q4
$268K Buy
2,430
+200
+9% +$20K 0.1% 174
2023
Q3
$216K Hold
2,230
0.1% 172
2023
Q2
$243K Hold
2,230
0.11% 164
2023
Q1
$226K Hold
2,230
0.11% 162
2022
Q4
$245K Buy
2,230
+108
+5% +$11.2K 0.13% 144
2022
Q3
$205K Hold
2,122
0.12% 145
2022
Q2
$231K Buy
2,122
+225
+12% +$25.6K 0.13% 145
2022
Q1
$225K Buy
1,897
+333
+21% +$41.3K 0.11% 160
2021
Q4
$220K Buy
+1,564
New +$200K 0.11% 157

Other funds holding ABT

Brown, Lisle/Cummings's ABT Position: Q2 2026 in Review

Brown, Lisle/Cummings increased its Abbott (ABT) stake by 8.4% in Q2 2026, buying an estimated $36K and bringing the position to 5,100 shares worth $463K. The position accounts for 0.1% of the portfolio, ranked #167.

Brown, Lisle/Cummings first reported a position in ABT in Q4 2021 and has held it in 19 quarters since. The position peaked at $590K in Q4 2025. 2,968 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

  • Brown, Lisle/Cummings held 5,100 shares of Abbott worth $463K as of Q2 2026.
  • Brown, Lisle/Cummings bought 394 Abbott shares in Q2 2026, an estimated $36K.
  • Abbott made up 0.1% of Brown, Lisle/Cummings's portfolio in Q2 2026, its #167 holding.
  • Brown, Lisle/Cummings first reported a position in Abbott in Q4 2021 and has held it in 19 quarters since.
  • Brown, Lisle/Cummings's Abbott position peaked at $590K in Q4 2025.
  • 2,968 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on Brown, Lisle/Cummings's 13F filing for Q2 2026, filed 2 Sep 2026.